Summary
1.Shift work insomnia, an approved indication for provigil, is both vastly underdiagnosed and under treated. Jet lag is indeed a forme fruste of this condition 2. Currently available techniques for coping with Jet lag are either ineffective ( such as over the counter stimulants and sedatives) or onerous,( chronotherapy involving shifting bedtime). 3. Nuvigil a superb agent with low risk for abuse should be approved for jet lag dyssomnia, and should expand its market vastly.
Analysis
As a sleep disorders specialist, I examine a wide variety of shift work insomnia. Although, one conventionally associates this disease entity with the blue-collar factory or service industry, the business and recreational travelers indeed experience the same symptom complex traveling across several time zones.
Indeed, most individuals who have had the opportunity to take modafanil for symptomatic jet lag do feel better. Although actigraphic and polysomnographic data using either maintenance of wakefulness or multiple sleep latency testing regarding the use of modafanil, I feel that jet lag is under diagnosed, and hence under treated
I hope that Cepahalon achieves the goal of FDA approval for the wide variety of conditions with jet lag hopefully imporving the productivity of a beleaguered work force.
